|
|
|||||||
Case Reports |
We describe the fourth case of e6a2 BCR-ABL transcript in a patient with chronic myeloid leukemia (CML), using reverse transcriptase polymerase chain reaction (RT-PCR) and sequencing analysis. The clinical and hematologic features and the aggressive course of disease in our patient and in the others reported in literature lead us to hypothesize that this atypical rearrangement may be associated with a worse prognosis.
This article has been cited by other articles:
![]() |
D. S. Ritchie, M. McBean, D. A Westerman, S. Kovalenko, J. F. Seymour, and A. Dobrovic Complete molecular response of e6a2 BCR-ABL-positive acute myeloid leukemia to imatinib then dasatinib Blood, March 1, 2008; 111(5): 2896 - 2898. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Burmeister, S. Schwartz, A. Taubald, E. Jost, T. Lipp, F. Schneller, H. Diedrich, H. Thomssen, U. J.M. Mey, J. Eucker, et al. Atypical BCR-ABL mRNA transcripts in adult Acute lymphoblastic leukemia Haematologica, December 1, 2007; 92(12): 1699 - 1702. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | TABLE OF CONTENTS | ARCHIVE | SUBSCRIPTIONS |